Literature DB >> 11553484

Strand displacement recognition of mixed adenine-cytosine sequences in double stranded DNA by thymine-guanine PNA (peptide nucleic acid).

P E Nielsen1, M Egholm.   

Abstract

Mixed pyrimidine-purine peptide nucleic acids (PNAs) composed of thymines and guanines are shown to form a PNA(2)-DNA triplex with Watson-Crick complementary adenine-cytosine oligonucleotides and to bind complementary adenine-cytosine targets in double stranded DNA by helix invasion. These results for the first time demonstrate binding of an unmodified PNA oligomer to a mixed pyrimidine-purine target in double stranded DNA and illustrate a novel binding mode of PNA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11553484     DOI: 10.1016/s0968-0896(01)00244-9

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  5 in total

1.  Effects of peptide nucleic acids against Ki-67 gene on the proliferation and apoptosis of human renal carcinoma cell line.

Authors:  Haibiao Lai; Junnian Zheng; Song Wu; Xiaoqing Sun; Jiachun Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

Review 2.  DNA triple helices: biological consequences and therapeutic potential.

Authors:  Aklank Jain; Guliang Wang; Karen M Vasquez
Journal:  Biochimie       Date:  2008-02-21       Impact factor: 4.079

3.  Selection of RNA aptamers that bind HIV-1 LTR DNA duplexes: strand invaders.

Authors:  Chatchawan Srisawat; David R Engelke
Journal:  Nucleic Acids Res       Date:  2010-08-06       Impact factor: 16.971

4.  End invasion of peptide nucleic acids (PNAs) with mixed-base composition into linear DNA duplexes.

Authors:  Irina V Smolina; Vadim V Demidov; Viatcheslav A Soldatenkov; Sergey G Chasovskikh; Maxim D Frank-Kamenetskii
Journal:  Nucleic Acids Res       Date:  2005-10-04       Impact factor: 16.971

5.  Versatile and efficient chromatin pull-down methodology based on DNA triple helix formation.

Authors:  Asako Isogawa; Robert P Fuchs; Shingo Fujii
Journal:  Sci Rep       Date:  2018-04-12       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.